↗7 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$2.8MSold on the market
1Companies
Oct 13, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 202616:34 | Oct 12, 2026 | ORKAOruka Therapeutics, Inc. | Senior Vice President, Finance | S · Sell10b5-1 | $80.60 | −9,999 | 14,219 | -41% | −$806K | ||
| Oct 13, 202616:34 | Oct 12, 2026 | ORKAOruka Therapeutics, Inc. | Senior Vice President, Finance | M · Exercise10b5-1 | $15.69 | +9,999 | 24,218 | +70% | $157K | ||
| Sep 21, 202617:38 | Sep 21, 2026 | ORKAOruka Therapeutics, Inc. | Senior Vice President, Finance | S · Sell10b5-1 | $95.75 | −533 | 14,219 | -4% | −$51K | ||
| Sep 15, 202619:17 | Sep 15, 2026from Sep 11, 2026 | ORKAOruka Therapeutics, Inc. | Senior Vice President, Finance | S · Sell10b5-1 | $92.43 | −10,019 | 14,752 | -40% | −$926K | ||
| Sep 15, 202619:17 | Sep 11, 2026 | ORKAOruka Therapeutics, Inc. | Senior Vice President, Finance | M · Exercise10b5-1 | $15.88 | +9,459 | 24,771 | +62% | $150K | ||
| Aug 14, 202617:42 | Aug 13, 2026 | ORKAOruka Therapeutics, Inc. | Senior Vice President, Finance | S · Sell10b5-1 | $106.66 | −10,000 | 15,312 | -40% | −$1.1M | ||
| Aug 14, 202617:42 | Aug 13, 2026 | ORKAOruka Therapeutics, Inc. | Senior Vice President, Finance | M · Exercise10b5-1 | $15.69 | +10,000 | 25,312 | +65% | $157K |